Keywords
medication
nonadherence
lifestyle
chronic disease
eligibility
insurance
How to Cite
Abstract
Background: Arterial hypertension is one of the most prevalent who did not modifiable risk factors for cardiovascular disease. For an optimal control of this disease, it is important that patients have a good adherence to treatment, however, non compliance with treatment is still a frequent problem.
Purpose: To characterize sociodemographically adherence to pharmacological treatment and identify the factors associated with therapeutic non-compliance in patients with arterial hypertension attending in a university hospital of Colombia.
Methodology: This was an observational, descriptive, cross-sectional study. The entire population with a diagnosis of arterial hypertension who received care between April 1 and May 31, 2021 was included. The Morisky scale (MMAS-8) was used to assess adherence to pharmacological treatment.
Results: 400 patients were included, of wich 56% were men. 14% of the patients were adherent to pharmacological treatment versus 86% who did not. The most frequently cause of non-adherence was the failure of the health insurers to supply medicines (49%).
Conclusion: Non- adherence to pharmacological treatment remains a major barrier to achieving adequate control of chronic diseases.
References
Berenguer Guarnaluses LJ. Algunas consideraciones sobre la hipertensión arterial. Medisan. 2016;20(11):2434.
Tagle R. Diagnóstico de la hipertensión arterial. Revista Médica Clínica Condes. 2018;29(1):12-20. https://doi.org/10.1016/j.rmclc.2017.12.005
Wyss F, Valdez O, Camafort M, Coca A. Abordaje terapéutico integral de la hipertensión arterial. Recomendaciones para Centroamérica y el Caribe. Hipertens Riesgo Vasc. 2023;40(1):40-7. https://doi.org/10.1016/j.hipert.2022.05.004.
Lear SA, Hu W, Rangarajan S, Gasevic D, Leong D, Iqbal R, et al. The effect of physical activity on mortality and cardiovascular disease in 130?000 people from 17 high-income, middle-income, and low-income countries: the PURE study. Lancet. 2017;390(10113):2643-54. http://dx.doi.org/10.1016/S0140-6736(17)31634-3
Unger T, Borghi C, Charchar F, Khan NA, Poulter NR, Prabhakaran D, et al. 2020 International Society of Hypertension. Global Hypertension Practice Guidelines. Hypertension. 2020;75(6):1334-57. https://doi.org/10.1161/hypertensionaha.120.15026
Guerra MG. Hypertensive Patient Adherence To Treatment: the Use of Therapeutic Communication Associated With Technology Educational in Health Promotion. 2017;(Dl):23-5. https://app.dimensions.ai/details/grant/grant.4477194
García-Peña ÁA, Ospina D, Rico J, Fernández-Ávila DG, Muñoz-Velandia Ó, Suárez-Obando F. Prevalence of arterial hypertension in Colombia according to data from the Comprehensive Social Protection Information System (SISPRO). Rev Colomb Cardiol. 2022;29(1):29-35. https://doi.org/10.24875/rccar.m22000114
Zurique-Sánchez MS, Zurique-Sánchez CP, Camacho-López PA, Sánchez-Sanabria MS, Hernández-Hernández SC. Prevalencia de hipertensión arterial en Colombia: revisión sistemática y metaanálisis. Acta Méd Colomb. 2019;44(4). https://doi.org/10.36104/amc.2019.1293
Zyoud SH, Al-Jabi SW, Sweileh WM, Wildali AH, Saleem HM, Aysa HA, et al. Health-related quality of life associated with treatment adherence in patients with hypertension: a cross-sectional study. Int J Cardiol. 2013;168(3):2981-3. http://dx.doi.org/10.1016/j.ijcard.2013.04.105
Holguín Palacios LE, Correa D, Arrivillaga M, Cáceres D, Varela M. Adherencia al tratamiento de hipertensión arterial: efectividad de un programa de intervención biopsicosocial. Univ Psychol. 2006;5(3):511-48.
Valencia-Monsalvez F, Mendoza-Parra S, Luengo-Machuca L. Evaluation of Morisky medication adherence scale (MMAS-8) in older adults of a primary health care center in Chile. Rev Peru Med Exp Salud Pública. 2017;34(2):245-9. https://doi.org/10.17843/rpmesp.2017.342.2206
Suárez-Argüello J, Blanco-Castillo L, Perea-Rangel JA, Villarreal-Ríos E, Vargas-Daza ER, Galicia-Rodríguez L, et al. Disease belief, medication belief and adherence to treatment in patients with high blood pressure. Arch Cardiol Mex. 2022;92(3):327-33. https://doi.org/10.24875/acm.21000026
Delucchi A, Marín M, Páez O, Bendersky M, Rodríguez P. Principales conclusiones del Consenso Argentino de Hipertensión Arterial. Hipertens Riesgo Vasc. 2019;36(2):96-109. http://dx.doi.org/10.1016/j.hipert.2019.01.001
Díaz Molina M, Herrera Preval Y, Matéu López L. Adherencia al tratamiento antihipertensivo en pacientes del municipio San Miguel del Padrón. Rev Cubana Farm. 2014;48(4):588-97.
Kripalani S, Yao X, Haynes RB. Interventions to enhance medication adherence in chronic medical conditions: a systematic review. Arch Intern Med. 2007;167(6):540-50. https://doi.org/10.1001/archinte.167.6.540
Guarín-Loaiza GM, Pinilla-Roa AE. Adherencia al tratamiento antihipertensivo y su relación con la calidad de vida en pacientes de dos hospitales de Bogotá, D.C. 2013-2014. Rev Fac Med. 2016;64(4):651. https://doi.org/10.15446/revfacmed.v64n4.52217
Varleta P, Akel C, Acevedo M, Salinas C, Pino J, Opazo V, et al. Prevalencia y determinantes de adherencia a terapia antihipertensiva en pacientes de la Región Metropolitana. Rev Méd Chile. 2015;143(5):569-76. http://dx.doi.org/10.4067/S0034-98872015000500003
Perseguer-Torregrosa Z, Orozco-Beltrán D, Gil-Guillen VF, Pita-Fernandez S, Carratalá-Munuera C, Pallares-Carratalá V, et al. Magnitude of pharmacological nonadherence in hypertensive patients taking antihypertensive medication from a community pharmacy in Spain. J Manag Care Spec Pharm. 2014;20(12):1217-25. https://doi.org/10.18553/jmcp.2014.20.12.1217
Natarajan N, Putnam W, Van Aarsen K, Lawson KB, Burge F. Adherence to antihypertensive medications among family practice patients with diabetes mellitus and hypertension. Can Fam Physician. 2013;59(2):e93-100.
Caro JJ, Speckman JL, Salas M, Raggio G, Jackson JD. Effect of initial drug choice on persistence with antihypertensive therapy: The importance of actual practice data. CMAJ. 1999;160(1):41-6.
Fernandez-Arias M, Acuna-Villaorduna A, Miranda JJ, Diez-Canseco F, Malaga G. Adherence to pharmacotherapy and medication-related beliefs in patients with hypertension in Lima, Peru. PLoS ONE. 2014;9(12): e112875. https://doi.org/10.1371/journal.pone.0112875
Castaño-Castrillón JJ, Echeverri-Rubio C, Giraldo-Cardona JF, Maldonado-Mora Á, Melo-Parra J, Meza-Orozco GA, et al. Treatment adherence of hypertensive patients’ being attended by Assbasalud ESE, Manizales (Colombia) 2011. Rev Fac Med. 2012;60(3):179-97.
Rosas-Chavez G, Romero-Visurraga CA, Ramirez-Guardia E, Málaga G. El grado de alfabetización en salud y adherencia al tratamiento en pacientes con hipertensión arterial en un hospital de Lima, Perú. Rev Peru Med Exp Salud Pública. 2019;36(2):214-21. https://doi.org/10.17843/rpmesp.2019.362.4279
Kunert J. Adherencia al tratamiento antihipertensivo en pacientes ambulatorios de un hospital urbano. Rev Virtual Soc Parag Med Int. 2015;2(2):43-51. https://doi.org/10.18004/rvspmi/2312-3893/2015.02(02)43-051
Al-Noumani H, Wu JR, Barksdale D, Sherwood G, AlKhasawneh E, Knafl G. Health beliefs and medication adherence in patients with hypertension: A systematic review of quantitative studies. Patient Educ Couns. 2019;102(6): 1045-1056. https://doi.org/10.1016/j.pec.2019.02.022
Rodríguez López MR, Varela MT, Rincón-Hoyos H, Velasco MM, Caicedo DM, Méndez F, et al. Prevalencia y factores asociados a la adherencia al tratamiento no farmacológico en pacientes con hipertensión y diabetes en servicios de baja complejidad. Rev Fac Nac Salud Pública. 2015;33(2):192-9. https://doi.org/10.17533/udea.rfnsp.v33n2a06
DiMatteo MR, Giordani PJ, Lepper HS, Croghan TW. Patient adherence and medical treatment outcomes: a meta-analysis. Med Care. 2002;40(9):794-811. https://doi.org/10.1097/00005650-200209000-00009
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.